OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commercial Milestones Approaching in 2026 Highlights Extensive Engagement with Altai Altai Has Rejected All Settlement Proposals and Is Singularly Focused on Securing Board Representation for Its Founder to

#OSUR OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital

www.stocktitan.net/news/OSUR/ora-sure-highl...

Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance Altai Capital Management, L.P., one of the largest shareholders and the beneficial owners of approximately 5% of the outstanding common stock of OraSure Technologies, Inc., today announced that it has delivered a letter to the OraSure Board of Directors outlining a five-pillar case for why change is necessary to preserve and deliver value for its investors.

#OSUR Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance

www.stocktitan.net/news/OSUR/altai-capital-...

OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates OraSure Technologies (NASDAQ: OSUR) confirmed on Dec 17, 2025 that activist investor Altai Capital intends to nominate two director candidates, including founder Rishi Bajaj, for election at the 2026 annual meeting. The company said its Board evaluated Mr. Bajaj and declined to appoint him, has engaged with Altai, and that shareholders are not required to take action now.OraSure highlighted corporate actions and financials: $216 million cash on hand as of Sept 30, 2025 with no debt, a $40 million share repurchase program, recent Board refresh (seven departures, three additions), and operational steps to improve margins.

#OSUR OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates

www.stocktitan.net/news/OSUR/ora-sure-techn...

#OSUR OraSure Announces Third Quarter 2025 Financial Results

www.stocktitan.net/news/OSUR/ora-sure-annou...

Trade Alerts, Monday November 3, 2025 – Crystal Equity Research

Small-cap stocks in new downtrend according to ave directional index, Mon Nov 3rd - #XBIT #UDMY #BNGO #FSUN #GBIO #HTOO #KPET #LINC #OSUR #PNBK #RBBN #SHFS #VRE #SKLZ #PBI #OMI #MLR #KW #HNI #GBX #EIG #DFIN #CION #AHH - More: crystalequityresearch.com/trade-alerts... - #smallcap

OraSure Earnings: Core Revenue Declines 5% as Company Pivots from COVID Testing to New Growth Markets OraSure reports $18M operating loss while launching new blood collection device. Core diagnostics up 3%, but sample management down 22%. See full financial details.

#OSUR OraSure Announces Second Quarter 2025 Financial Results

www.stocktitan.net/news/OSUR/ora-sure-annou...

Revolutionary Blood Collection Technology Enables 7-Day Protein Preservation at Room Temperature: OraSure's Latest Innovation New HEMAcollect PROTEIN device preserves plasma proteins at room temperature for 7 days, transforming proteomic research workflow efficiency. Learn more.

#OSUR OraSure Launches Novel Blood Collection Device for Proteomic Research

www.stocktitan.net/news/OSUR/ora-sure-launc...

OraSure Announces First Quarter 2025 Financial Results OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended March 31, 2025. “Our Q1 results were consistent with

#OSUR OraSure Announces First Quarter 2025 Financial Results

www.stocktitan.net/news/OSUR/ora-sure-annou...

OraSure Unveils Major $40M Stock Buyback: Management Signals Strong Confidence New $40M share repurchase program demonstrates management confidence in OraSure's future. 24-month buyback plan aims to enhance shareholder returns. Full analysis inside.

#OSUR OraSure Announces $40 Million Stock Repurchase Program

www.stocktitan.net/news/OSUR/ora-sure-annou...

Two additional #OSUR insider purchases were filed yesterday, March 3

#insidertrading #insidealert #econsky #finsky #stockmarket

Four #OSUR insider purchases were filed yesterday, February 27:

#stockmarket #insidertrading #insidealert #econsky #finsky

OraSure's Post-COVID Reality: Can 10% Core Growth Offset the 51% Revenue Plunge? OraSure reports mixed Q4 results with core business up 10% while total revenue fell 51% due to COVID decline. $267.8M cash position supports Sherlock acquisition.

#OSUR OraSure Reports Fourth Quarter 2024 Financial Results

www.stocktitan.net/news/OSUR/ora-sure-repor...

FDA Expands OraSure's HIV Self-Test Access to Teens Amid Rising Youth Diagnoses OraSure's OraQuick HIV Self-Test now approved for ages 14+, targeting critical youth demographic as CDC data shows 19% of new HIV cases affect ages 13-24.

#OSUR CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

www.stocktitan.net/news/OSUR/correction-ora...

OraSure Expands OraQuick HIV Self-Test Access to Teens 14+ Amid Rising Youth Cases OraSure's OraQuick HIV Self-Test now approved for ages 14+, addressing important need as CDC data shows 19% of new HIV cases occur in youth with low testing rates.

#OSUR OraQuick® HIV Self-Test Now Approved for Use in Adolescents

www.stocktitan.net/news/OSUR/ora-quick-hiv-...

OraSure Expands Into $1.5B Molecular Testing Market with Sherlock Biosciences Acquisition OraSure acquires Sherlock's rapid molecular diagnostic technology, targeting the $1.5B CT/NG testing market with 30-minute self-test solutions pending FDA approval.

#OSUR OraSure Technologies Acquires Sherlock Biosciences

www.stocktitan.net/news/OSUR/ora-sure-techn...

OraSure Lands $7.5M Federal Contract to Develop Marburg Virus Rapid Test | OSUR Stock News OraSure Technologies secures federal funding to develop a rapid antigen test for Marburg Virus Disease, with potential contract value reaching $11M through BARDA partnership.

#OSUR OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test

#investing #news #stocks

www.stocktitan.net/news/OSUR/ora-sure-recei...

#OSUR OraSure to Participate in Upcoming Investor Conference

www.stocktitan.net/news/OSUR/ora-sure-to-pa...